{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-299814","form_type":"8-K","ticker":"OSCR","cik":"0001568651","company_name":"Oscar Health, Inc.","filed_at":"2022-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.209204+00:00","generated_at":"2026-06-21T08:07:50.108659+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Oscar Health expands board to 10, appoints Laura Lang and Bill Gassen as independent directors","bullets":["Board size expanded from 8 to 10; appointments effective December 7, 2022.","Laura Lang appointed as Chair of Compensation Committee; Bill Gassen joins Nominating Committee.","Both independent under NYSE rules; Gassen is president/CEO of Sanford Health.","Lang served as CEO of Time Inc. and Digitas; also on boards of VF Corp and Vroom.","Standard director compensation: $70k annual cash retainer, $175k initial RSU grant, $175k annual RSU."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-299814","json":"https://secwatch.observer/filing/0001193125-22-299814.json","markdown":"https://secwatch.observer/filing/0001193125-22-299814.md","text":"https://secwatch.observer/filing/0001193125-22-299814.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1568651/000119312522299814/0001193125-22-299814-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1568651/000119312522299814/d409911d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T08:07:50.108659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f8cba465c","claim":"Laura Lang was appointed as Director at Oscar Health, Inc..","evidence_excerpt":"On December 6, 2022, the Board of Directors (the “Board”) of Oscar Health, Inc. (the “Company”) increased the size of the Board from a total of eight directors to ten directors and appointed Ms. Laura Lang and Mr. Bill Gassen to the Board, effective as of December 7, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000119312522299814/0001193125-22-299814-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b1f418340d","claim":"Bill Gassen was appointed as Director at Oscar Health, Inc..","evidence_excerpt":"On December 6, 2022, the Board of Directors (the “Board”) of Oscar Health, Inc. (the “Company”) increased the size of the Board from a total of eight directors to ten directors and appointed Ms. Laura Lang and Mr. Bill Gassen to the Board, effective as of December 7, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000119312522299814/0001193125-22-299814-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}